Trials / Completed
CompletedNCT02488447
Study for Evaluating Life Quality in Patients With Rhinoconjunctivitis
Prospective Study for Evaluating Life Quality and Its Determinant Factors as Treatment Adherence and Immunotherapy Satisfaction in Patients With Rhinoconjunctivitis With or Without Asthma, Sensitized at Least to One Aeroallergen
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 215 (actual)
- Sponsor
- Roxall Medicina España S.A · Industry
- Sex
- All
- Age
- 12 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of ths study is to evaluate changes in life quality of patients affected by rhinoconjuntivitis with or without asthma after immunotherapy treatment. It is an observational, prospective and comparative study before-after immunotherapy treatment with a one year follow-up.
Conditions
Timeline
- Start date
- 2015-05-01
- Primary completion
- 2017-05-25
- Completion
- 2017-05-25
- First posted
- 2015-07-02
- Last updated
- 2017-10-20
Locations
14 sites across 1 country: Spain
Source: ClinicalTrials.gov record NCT02488447. Inclusion in this directory is not an endorsement.